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8-Oxo-7,8-dihydroguanineOxidative damage to guanine (8-oxoGua) is one of the most abundant lesions induced by oxidative stress and
documented mutagenic. 8-Oxoguanine DNA glycosylase 1 (OGG1) removes 8-oxoGua from DNA by excision.
The urinary excretion of 8-oxoGua is a biomarker of exposure, reﬂecting the rate of damage in the steady
state. The aim of this study was to investigate urinary 8-oxoGua as a risk factor for lung cancer. In a nested
case-cohort design we examined associations between urinary excretion of 8-oxoGua and risk of lung cancer
as well as potential interaction with the OGG1 Ser326Cys polymorphism in a population-based cohort of
25,717 men and 27,972 women aged 50–64 years with 3–7 years follow-up. We included 260 cases with lung
cancer and a subcohort of 263 individualsmatched on sex, age, and smoking duration for comparison. Urine col-
lected at entry was analysed for 8-oxoGua by HPLC with electrochemical detection. There was no signiﬁcant ef-
fect of smoking or OGG1 genotype on the excretion of 8-oxoGua. Overall the incidence rate ratio (IRR) (95%
conﬁdence interval) of lung cancerwas 1.06 (0.97–1.15) per doubling of 8-oxoGua excretion. The association be-
tween lung cancer risk and 8-oxoGua excretion was signiﬁcant among men [IRR: 1.17 (1.03–1.31)], never-
smokers [IRR: 9.94 (1.04–94.7)], and former smokers [IRR: 1.19 (1.07–1.33)]. There was no signiﬁcant interac-
tion with the OGG1 genotype, although the IRR was 1.14 (0.98–1.34) among subjects homozygous for Cys326.
The association between urinary 8-oxoGua excretion and lung cancer risk among former and never-smokers
suggests that oxidative stress with damage to DNA is important in this group.
© 2011 Elsevier Inc.Open access under CC BY-NC-ND license.Introduction
Oxidative stress is thought to be important in carcinogenesis and lung
cancermay be an important example. Tobacco smoke and polluted ambi-
ent air contain gaseous oxidants as well as volatiles and especially parti-
cles, which can induce oxidative stress by multiple pathways [1,2]. The
DNA base oxidation product 8-oxo-7,8-dihydroguanine (8-oxoGua) is
one of the more abundant oxidative stress-induced lesions in DNA and
the level of this lesion in blood mononuclear cells and excretion of the
corresponding nucleoside in urine have consistently been found to be as-
sociated with exposure to ambient air pollution [3]. 8-OxoGua is aguanine DNA glycosylase 1; 8-
a, 8-oxo-7,8-dihydroguanine.
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-NC-ND license.mutagenic lesion unless removedmainly by 8-oxoguanine DNA glycosy-
lase 1 (OGG1) [4].
The urinary excretion of 8-oxoGua may be an important biomarker
of oxidative stress and may predict cancer risk [5,6]. It is important to
recognize that in the steady state the excretion reﬂects the rate of dam-
age [7]. Some case–control studies have shown increased 8-oxoGua or
the corresponding deoxynucleoside, 8-oxo-7,8-dihydro-2′-deoxygua-
nosine (8-oxodG), among cancer patients [8–10]. However, these ﬁnd-
ings may be due to reverse causality considering that diseases such as
cancer are associated with ongoing oxidative stress, inﬂammation,
and tissue turnover or even radiation or chemotherapy [11,12]. Pro-
spective studies are required and with such a design, we have found
that a high urinary excretion of 8-oxodG and OGG1 mRNA expression
in cells from buffy coat preparations were associated with a high risk
of lung cancer in a small group of never-smokers, whereas there was
no sign of association among former or current smokers [13,14].
The OGG1 enzyme shows a common genetic missense polymor-
phism, Ser326Cys, which in complementation assays in vitro appears
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species considerably, whereas 8-oxoGua levels and incision activity in
extracts from leukocytes and some target tissues show more variable
data in studies comparing the genotypes [15,16]. However, higher
levels of oxidised guanine have been found in human lymphocyte
DNA from Cys326 homozygous subjects as compared with heterozy-
gous or homozygous wild-type subjects, especially after ex vivo treat-
ment with sodium dichromate [17,18]. The homozygous Cys326
genotype has been associated with a moderately elevated risk of
lung cancer among nonsmokers and/or Asians in large meta-analyses
[19].
The aim of this study was to examine the association between 8-
oxoGua in urine sampled before cancer diagnosis and risk for lung
cancer as well as possible interactions with the OGG1 Ser326Cys poly-
morphism in a large population-based prospective Danish cohort for
which detailed information on smoking patterns and other lifestyle
factors at enrolment is available.
Materials and methods
Study population
We used the same study population as in our previous study on
the excretion of 8-oxodG and risk of lung cancer based on the pro-
spective Danish follow-up study, Diet, Cancer, and Health, which is
approved by the scientiﬁc ethics committees [13]. Invited to partici-
pate were 160,725 individuals aged 50–64 years, 57,053 individuals
with no previous cancer diagnosis were recruited. All participants
were born in Denmark and virtually all were Caucasians (race was
not registered). At enrollment (1993–1997), detailed information on
diet, smoking habits, lifestyle, reproduction, medical treatment, and
other socio-economic characteristics and environmental exposures,
including second-hand smoke, were collected. Body weight and
height were measured and spot urine samples were voided at the
clinic and stored at −150 °C.
Among the 57,053 persons recruited to the Diet, Cancer, and
Health study, 542 were later registered in the Danish Cancer Register
as having cancer diagnosed before the date of enrollment and were
therefore excluded. Among the 56,511 individuals with no previous
cancer diagnosis, we excluded 2291 individuals for whom informa-
tion regarding smoking habits was incomplete, inconsistent, or miss-
ing. Among the remaining 54,220 cohort members included in this
study, 265 cases of lung cancer, diagnosed between 1994 and 2001,
were identiﬁed in the ﬁles of the nationwide Danish Cancer Registry.
The three most common histological diagnoses were adenocarcinoma
(81 cases), small cell carcinoma (55 cases), and squamous cell carci-
noma (51 cases). Also from among the cohort members, a subcohort
was selected. For this procedure, we divided the entire cohort (inclu-
sive cases) in strata deﬁned by sex, year of birth (5-year intervals),
and duration of smoking (10-year intervals). For the subcohort, we
sampled 272 persons (including 4 of the cases) such that the number
of subcohort members in the different strata approximated the num-
ber of cases. We used a random procedure to select subcohort mem-
bers within each stratum. Urine was available for 490 of the 533
selected individuals, and laboratory analyses of urinary biomarkers
failed for 9 samples, leaving 481 persons (238 cases and 245 subco-
hort members (including 4 cases)) for analyses of lung cancer risk
in association with the urinary biomarker. Blood samples were not
available for a further 6 of these individuals, leaving 475 individuals
(231 cases and 244 subcohort members, including 4 cases) for ana-
lyses of lung cancer risk in association with combinations of the uri-
nary biomarker and OGG1 genotype. The DNA used for genotyping
and RNA for expression analysis by real-time RT-PCR were isolated
from buffy coat using standard procedures and the Ser326Cys OGG1
genotype OGG1mRNA levels were determined as previously reported
[14,20].Determination of 8-oxoGua
All urine samples were analysed coded and were subjected to two
freeze–thaw cycles. The urinary concentrations of 8-oxoGua were de-
termined by a recently developed high-performance liquid chromatog-
raphy method based on anion-exchange chromatography, precise
fraction collection, reversed-phase chromatography, and electrochemi-
cal detection as described elsewhere [21]. The urinary concentration of
creatinine was determined by a spectrometric method based on the
Jaffe reaction, which showed values similar to those of other methods
in a large interlaboratory validation exercise focused on measuring 8-
oxodG in urine [22].
Statistical methods
The data were sampled according to the case-cohort design and
the unweighted case-cohort approach was used for analyses [23]. In-
cidence rate ratios (IRR) for lung cancer were estimated by the Cox
proportional hazards model, stratiﬁed according to sex, year of birth
(5-year intervals), and duration of smoking (10-year intervals). Age
was the time axis. We calculated two-sided 95% conﬁdence intervals
(CI) and P values based on robust estimates of the variance–covariance
matrix [24] and Wald's test of the Cox regression parameter, that is, on
the log rate ratio scale.
The hypothesis of a linear association between urinary concentra-
tions of 8 oxoGua and risk of lung cancer was evaluated using a linear
spline with three boundaries, placed at the quartiles among cases, as
covariates in the Cox model [25]. The linearity of 8-oxoGua was eval-
uated graphically and by a numerical test using the likelihood ratio
test statistic to compare the model assuming linearity with the linear
spline model. It was found not to deviate from linearity. The linear ef-
fect of 8-oxoGua was estimated for each sex (men and women), for
each smoking status (never, former, and current), and for each
OGG1 genotype (homozygous wild type, Ser326/Ser326; heterozy-
gous type, Ser326/Cys326; and homozygous variant type, Cys326/
Cys326) and we tested (Wald test) the null hypothesis that the effect
of 8-oxoGua was the same by introduction of an interaction term.
Potential determinants of 8-oxoGua excretion related to sex, age,
OGG1 genotype, and smoking were examined by bivariate and multi-
variate GLM analysis. Moreover, we included intake of fruit and veg-
etables as a potential determinant because it was recently found in
this cohort that intake of fruit and vegetables was associated with a
low risk of lung cancer among subjects with the Cys326/Cys326
[26]. Overall correlations between 8-oxoGua excretion and previously
reported 8-oxodG excretion and levels of OGG1 mRNA expression in
buffy coat from 267 of the subjects were assessed by the Spearman
correlation [13,14].
Results
Only 8 never-smokers, 6 of whom were women, developed lung
cancer during the follow-up period. There was no difference with re-
spect to exposure to second-hand smoke between the never-smoker
cases and the subcohort members.
None of the possible determinants of the excretion of 8-oxoGua
summarized in Table 1 showed statistically signiﬁcant associations
in bivariate or multivariate analysis. Current smokers had slightly
higher median excretion of 8-oxoGua than former smokers, although
there was no signiﬁcant effects or sign of dose–response relationship
and never smokers had the highest median excretion. Women had
slightly higher levels of 8-oxoGua corrected for creatinine than men
did, although the difference did not attain statistical signiﬁcance.
There was no sign of association between 8-oxoGua excretion and
age, intake of fruit and/or vegetables, or with the OGG1 genotype. Ex-
cretion of 8-oxoGua was positively correlated to the previously
reported OGG1 mRNA levels in buffy coat measured in 292 of the
Table 1
Excretion of 8-oxoguanine (8-oxoGua) according to gender, smoking, oxoguanine DNA glycosylase (OGG1) genotype, age, and fruit and vegetable intake among subsequent cases of
lung cancer and a matched subcohort.
N 8-OxoGua (nmol/mmol creatinine)
Cases/subcohort Cases a Subcohort a
All 238/245 8.27 (3.07–55.4) 7.90 (3.15–62.1)
Sex
Men 128/135 7.27 (3.05–63.7) 7.57 (3.33–52.6)
Women 110/110 9.65 (3.54–51.3) 9.61 (3.01–70.4)
Smoking status at inclusion
Never 8/7 14.2 (7.27–58.1) 10.3 (2.81–19.1)
Former 32/53 6.91 (2.87–51.3) 7.64 (3.25–29.3)
Current 198/185 8.36 (3.07–55.4) 7.92 (3.15–64.2)
Of≤18 g tobacco per day 75/102 9.20 (4.37–59.6) 7.83 (3.06–52.6)
Of>18 g tobacco per day 123/83 7.82 (3.07–49.3) 8.25 (3.46–66.0)
OGG1 genotype
Ser326/Ser326 130/143 8.34 (4.27–37.6) 7.66 (3.25–70.4)
Ser326/Cys326 87/82 8.05 (2.86–59.6) 8.27 (3.92–31.3)
Cys326/Cys326 14/19 7.51 (2.87–194) 9.66 (1.90–56.7)
Age at inclusion
50–55 years 32/73 6.28 (3.49–64.3) 7.35 (2.81–66.1)
56–60 years 61/74 7.92 (3.05–49.3) 7.39 (3.18–29.3)
≥ 61 years 145/98 8.98 (4.01–45.3) 9.19 (3.06–66.0)
Intake of fruit
b 129.5 g/day 131/112 8.24 (3.05–45.3) 7.29 (3.15–64.2)
≥ 129.5 g/day 107/133 8.66 (3.72–58.1) 8.29 (3.11–62.1)
Intake of vegetables
b 128.2 g/day 137/112 8.24 (2.87–59.6) 7.70 (3.06–64.2)
≥ 128.2 g/day 101/133 8.31 (3.73–45.3) 8.32 (3.15–62.1)
None of these factors were signiﬁcantly associated with the excretion in bivariate or multivariate analysis in either group.
a Median with 5–95% percentiles.
Table 2
Incidence rate ratio (IRR) of lung cancer in relation to excretion of 8-oxoguanine
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magnitude of correlation between 8-oxoGua and OGG1 mRNA ex-
pression as the correlation between 8-oxodG and OGG1 mRNA levels
with absolute levels reported elsewhere [14], whereas 8-oxoGua and
8-oxodG excretion were also signiﬁcantly correlated (Rs=0.41,
Pb0.05).8-oxoGua and 8-oxodG per creatinine (nmol/mmol)
1 5 50 500







Fig. 1. Correlation between oxidatively damaged nucleobase lesions in urine (8-oxoGua
or 8-oxodG) and OGG1mRNA expression level relative to 18S RNA in leukocytes. Regres-
sion lines shown are based on a linear scale. There was similar magnitude of correlation
for 8-oxoGua (Rs=0.13, P=0.03) and 8-oxodG (Rs=0.17, P=0.004). The correlation
between OGG1mRNA and 8-oxodG has been reported previously [14] and is depicted in
the graph for comparison with 8-oxoGua. There was about one order of magnitude larger
urinary excretion of 8-oxoGua as compared to 8-oxodG.Overall the association between 8-oxoGua excretion and risk of
lung cancer was not signiﬁcant (Table 2). However, among men









IRR 95% CI P a IRR 95% CI P a
All 238/245 1.05 0.97–1.13 1.06 0.97–1.15
Sex 0.06 0.06
Men 128/135 1.15 1.03–1.30 1.17 1.03–1.31
Women 110/110 1.01 0.92–1.10 1.01 0.92–1.11
Smoking status 0.02 0.02
Never 8/7 6.69 0.72–62.4 9.94 1.04–94.7
Former 32/53 1.20 1.09–1.32 1.19 1.07–1.33
Current 198/185 1.02 0.93–1.11 1.03 0.94–1.13
Histology
Adenocarcinomas 74/241 1.03 0.93–1.14 1.03 0.91–1.17
Squamous cell
carcinomas
50/241 1.04 0.89–1.22 1.03 0.87–1.22
Small cell
carcinomas
51/242 1.08 0.97–1.20 1.10 0.98–1.24
OGG1 genotype 0.31 0.52
Ser326/Ser326 130/143 1.03 0.90–1.16 1.04 0.91–1.19
Ser326/Cys326 87/82 1.02 0.91–1.15 1.02 0.90–1.15
Cys326/Cys326 14/19 1.17 1.01–1.36 1.14 0.98–1.34
Age – –
50–55 years 32/73 1.05 0.87–1.27 1.11 0.86–1.42
56–60 years 61/74 1.07 0.97–1.19 1.08 0.96–1.21
≥ 61 years 145/98 1.04 0.95–1.15 1.06 0.95–1.19
Intake of fruit 0.87 0.72
b 129.5 g/day 131/112 1.04 0.90–1.20 1.03 0.87–1.20
≥ 129.5 g/day 107/133 1.06 0.97–1.16 1.06 0.97–1.16
Intake of vegetables 0.45 0.51
b 128.2 g/day 137/112 1.10 0.97–1.25 1.10 0.97–1.26
≥ 128.2 g/day 101/133 1.03 0.93–1.14 1.04 0.93–1.16
a P value for interaction.
b Adjusted for smoking status, intensity, duration, and intake of fruit and/or vegeta-
bles at entry.
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cretion was borderline signiﬁcant. Among never and former smokers
there were also signiﬁcant associations between high excretion of
8-oxoGua and high risk of lung cancer with a signiﬁcant interaction
term. The excretion of 8-oxoGua was not signiﬁcantly associated with
a speciﬁc histological form of lung cancer, although the IRR for small
cell cancer appeared slightly higher than those for squamous cell and
adenocarcinoma.
There was no signiﬁcant interaction between OGG1 genotype and
8-oxoGua excretion (Tables 1 and 2). However, the association be-
tween excretion and risk of lung cancer was signiﬁcant among sub-
jects homozygous for Cys326 in unadjusted analysis, although this
lost signiﬁcance after adjustment for smoking intensity and duration
as well as fruit and vegetable intake (Table 2). There were no never-
smokers homozygous for Cys326. Age and the intake of fruit and/or
vegetables had no signiﬁcant inﬂuence on the association between
8-oxoGua excretion and risk of lung cancer. Similarly, adjustment
for time since quitting smoking among ex-smokers had no effect on
the risk estimates (data not shown).
Discussion
In this study, we found signiﬁcant associations between urinary
excretion of 8-oxoGua and risk of lung cancer among former and
never-smokers and among men sampled from a large cohort study,
whereas no such association was apparent among women or current
smokers at the time of urine collection.
The association between 8-oxoGua excretion and lung cancer risk
among the never-smokers was similar to our previously reported 12-
fold higher risk of lung cancer per doubling of the excretion of 8-
oxodG and comparable risk associated with high OGG1mRNA expres-
sion in the same subjects [13,14]. The urinary excretion of 8-oxodG
putatively stems from sanitization of the nucleotide pool for 8-
oxoGua in dGTP, whereas 8-oxoGua is a direct product of base exci-
sion repair of DNA [7]. It is therefore of importance that we found a
signiﬁcant association between risk of lung cancer and 8-oxoGua ex-
cretion among former smokers representing 32 cases, whereas we
found no such association for 8-oxodG excretion or OGG1 mRNA ex-
pression in this population [13,14]. The risk associated with a high ex-
cretion of 8-oxoGua among former smokers was robust to adjustment
for smoking duration, intensity, and time since quitting as potential
confounders. Although interpretation is more complex such adjust-
ment should leave associations to indicate effects acting via 8-
oxoGua through other mechanisms. Similarly, the polymorphism in
OGG1 appears mainly relevant for lung cancer risk among non-
smokers [19]. Accordingly, oxidative damage to DNA may be impor-
tant for the development of lung cancer among nonsmokers,
although the causative agents in this respect so far are unknown. It
might be speculated that the lung cancer promotion in never-
smokers and former smokers is partly caused by similar oxidative
stress-related risk factors detected by 8-oxoGua excretion, although
cancer initiation caused by the earlier smoking habit of the latter
may be most important for their absolute risk. Whether the associa-
tion is related to unknown exposures causing oxidative stress or a
poor antioxidant defense due to genetic or other factors cannot be
assessed from our data. Stratiﬁed analysis according to histological di-
agnosis was not helpful in this respect with a slightly higher risk for
small cell carcinoma than for adenocarcinoma or squamous cell carci-
noma associated with high 8-oxoGua excretion. Further stratiﬁcation
for both smoking, sex, or OGG1 genotype and histological diagnosis
would have had too low power; for instance, there were only two
never-smoking men among the cases.
8-OxoGua excreted into urine can originate from all cells in the body
and represents in steady state an average rate of oxidative damage to
the DNA [7]. The contribution from the lungs to urinary 8-oxoGua is un-
known and at present it can be considered as a biomarker of generaloxidative stress-induced DNA damage [27]. Prospective studies of the
levels of 8-oxoGua in cells, e.g., lymphocytes, would be of large interest.
However, this requires isolation at collection and cryopreservation of
the cells in media that diminish spurious oxidation of DNA during stor-
age, which has not been included in our or other large biobanks, and
thus impossible at present [12].
Several published studies [8,28–31], but not all [32], show that
smoking is associated with increased excretion of 8-oxoGua, similarly
to the more established notion that smokers excrete more 8-oxodG
than nonsmokers [33–36]. In the present material the urinary excre-
tion of 8-oxoGua had no obvious association with smoking. An effect
of current smoking on 8-oxoGua excretion might have complicated
the interpretation of associations with the risk of cancer dependent
on the understanding of possible causal pathways. Thus, 8-oxoGua
excretion could then have been interpreted as a step on the causal
pathway from smoking to cancer. However, we only found associa-
tions among former and never-smokers at urine sampling and associ-
ations found without or with adjustment for smoking, which should
be through other pathways, were very similar.
With the present matching procedure including smoking duration
in 10 year strata for the selection of the comparison group and with or
without further adjustment for smoking status, intensity, and dura-
tions there was a very weak association between excretion of 8-
oxoGua and risk of lung cancer among current smokers similar to
our earlier ﬁnding with respect to 8-oxodG excretion and OGG1
mRNA expression [13,14]. The adjusted association should indicate
effects related to 8-oxoGua excretion through other mechanisms
than smoking. Thus, the data do not support a speciﬁc predictive ca-
pacity of excretion of 8-oxoGua for lung cancer among current
smokers, who have a much larger absolute risk than nonsmokers.
Thus, even a relative risk of 1.03 can be substantial in absolute
terms. It is likely that the high risk of lung cancer associated with cur-
rent smoking involves so many mechanisms, including tobacco-
speciﬁc nitrosamines and polycyclic aromatic hydrocarbons, that
mechanisms involving oxidation of guanine in DNA cannot be
detected. Indeed, a high risk of lung cancer appears to be associated
with high levels of bulky DNA adducts in lymphocytes and high ex-
cretion of 7-methylguanine mainly among current smokers [37,38].
The present study was prospective and effects of cancer on the ex-
cretion of 8-oxoGua should thus not be relevant. Little is so far known
concerning environmental factors inﬂuencing the excretion of 8-
oxoGua. Several studies suggest that exposure to ambient air pollu-
tion, wood smoke, styrene, or nickel and cadmium might increase
8-oxoGua excretion [17,28,31,39,40]. Dietary purines have been
shown not to affect the 8-oxoGua excretion [41]. Similarly, the pre-
sent study showed no association with a high intake of fruit and/or
vegetables, whereas intervention with the chemopreventive agent
oltipraz, olive oil, or caloric restriction had no inﬂuence on 8-
oxoGua excretion [42–44]. In contrast, 8-oxoGua excretion was al-
most doubled 24 h after infusion of cisplatin, which is thought to in-
duce oxidative stress, whereas the excretion was almost at baseline
at the time of maximum cell death 7 to 12 days later [45]. Patients
with mixed Alzheimer disease/vascular dementia showed elevated
levels of 8-oxoGua in the cerebrospinal ﬂuid and the urine [46]. The
urinary excretion of 8-oxoGua has also been shown to correlate
with the metabolic rate and inversely with the maximum life span
across species in several studies [21,47]. These data support that ex-
cretion of 8-oxoGua reﬂects total body oxidative stress.
Although urinary 8-oxoGua is thought to be a product of OGG1 ac-
tivity the excretion was only reduced by 26% in ogg1−/−mice as com-
pared to wild-type mice [48]. Because the levels of 8-oxoGua in DNA
are usually higher and more induced by oxidative stress in ogg1−/−
mice [49,50], less capacity of backup repair enzymes, such as the
NEIL1 DNA glycosylase, would be required for this excretion [51], as-
suming ﬁrst-order kinetics. Moreover, the homozygous Cys326 geno-
type in humans has been associated with higher levels of oxidized
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chromate [18], in leukocyte DNA, leaving more substrate for an OGG1
enzyme with possibly decreased activity. This is consistent with 8-
oxoGua excretion in the present study and the results from two
other studies where the excretion of 8-oxoGua was not affected by
the OGG1 polymorphism [10,17]. Nevertheless, there was a weak pos-
itive correlation between 8-oxoGua excretion and OGG1 mRNA ex-
pression in buffy coat in this study. These observations support that
8-oxoGua excretion is a biomarker of the rate of damage to DNA. In
agreement we found that the association between 8-oxoGua and
lung cancer risk was mainly present in subjects homozygous for
Cys326 in OGG1, although this was not robust with respect to adjust-
ed analysis and there was no signiﬁcant interaction with the geno-
type. Similarly, among the same subjects homozygous for Cys326 in
OGG1 we previously found a signiﬁcant positive association between
the risk of lung cancer and the OGG1 mRNA expression in buffy coat,
which was weakly correlated with the excretion of 8-oxodG across all
subjects [14]. These data support that the output of 8-oxoGua from
DNA is equal to the inﬂux independent of the OGG1 enzyme, whereas
a reduced activity of OGG1 can give rise to elevated levels in the DNA
and possibly more error-prone repair with potentially more risk of
mutations. Indeed, the homozygous Cys326 OGG1 genotype has
been associated with an increased risk of lung cancer and an appar-
ently stronger protective effect of fruits and vegetables [26,53,54], al-
though we found no association with 8-oxoGua excretion or effect
modiﬁcation by intake of these in the present study.
As a biomarker, 8-oxoGua excretion is promising because it appears
to be stable during long-term storage.We have observed that 8-oxoGua
concentrations in samples stored at−130 °C for 9–13 years were simi-
lar to those measured in fresh samples [21,42,43,55–57]. All samples in
the present studywere treated identically and therewas no effect of ad-
justment for storage time in the freezer. However, urine was collected
only once, namely at enrollment, and this may not be representative
for the long period at risk. Ideally, multiple urine samples should be col-
lected repeatedly over time to have the best estimate of the actual ex-
cretion of 8-oxoGua or other biomarkers. However, in cohort studies
such as ours with 57,000 individuals it is virtually impossible to collect
more than one sample from each and our collection was from 1993 to
1997. Nevertheless, several large placebo-controlled intervention stud-
ies with repeated measurements within individuals over 8 weeks have
shown relatively constant levels of 8-oxoGua excretion within an indi-
vidual [42,43] and a short-term study showed no sign of diurnal varia-
tion [58]. Urine was collected as spot samples in the present study
and the concentrations of 8-oxoGuahad to be adjusted by the creatinine
concentration. We did not use an accurate method such as HPLC with
tandem mass spectrometry for this analysis, which might have intro-
duced some variation [59], although the Jaffe reaction we used showed
consensus with other methods [22]. Inaccuracy in the determination of
creatinine and most variation in 8-oxoGua excretion is likely to be ran-
dom and can result in nondifferential exposure misclassiﬁcation, which
is much more likely to drive the risk estimate toward zero, than to cre-
ate artiﬁcial associations. Accordingly, this cannot explain the associa-
tions we found among never and former smokers. On the other hand,
creatinine excretion is affected bymusclemass and this obscures differ-
ences related to sex and age [30]. However, age- and sex-associated dif-
ferences in the excretion of 8-oxoGua are not likely to affect our results
concerning risk of lung cancer because the subcohort for comparison
with the cases was selected with match on sex and because age was
used as the time axis in the statistical analyses, which ensured that
cases were comparedwith subcohort members at exactly the same age.
In conclusion, this population-based prospective cohort study in-
dicates that the excretion of the DNA damage product 8-oxoGua in
urine sampled before a cancer diagnosis is signiﬁcantly associated
with risk of lung cancer among never and former smokers and
among men. This suggests that oxidative damage to DNA is important
for development of lung cancer that is not related to smoking.Acknowledgments
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